ASP Isotopes (ASPI) EBIT (2022 - 2026)

ASP Isotopes' EBIT history runs 5 years deep, the most recent figure standing at -$24.9 million for Q1 2026.

• In Q1 2026, EBIT fell 212.98% year-over-year to -$24.9 million; the TTM figure through Mar 2026 stood at -$50.4 million (down 77.05% YoY), while the FY2025 annual figure was -$33.5 million, down 27.15% from the prior year.
• EBIT was -$24.9 million for Q1 2026 at ASP Isotopes, down from $1.4 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $1.4 million in Q4 2025 to a low of -$24.9 million in Q1 2026.
• Historically, EBIT has averaged -$6.2 million across 5 years, with a median of -$4.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: EBIT slumped 425.09% in 2023, then surged 118.04% in 2025.
• A 5-year view of EBIT shows it stood at -$1.5 million in 2022, then sank by 175.73% to -$4.0 million in 2023, then plunged by 90.1% to -$7.6 million in 2024, then soared by 118.04% to $1.4 million in 2025, then tumbled by 1903.66% to -$24.9 million in 2026.
• The last three EBIT figures came in at -$24.9 million (Q1 2026), $1.4 million (Q4 2025), and -$15.0 million (Q3 2025), per Business Quant data.